COmparison of Maintenance of Propofol And Sevoflurane Spectral Study

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCliniques universitaires Saint-Luc- Université Catholique de Louvain

About this trial

Lower EEG alpha band power is currently extensively studied as a potential biomarker of brain vulnerability. No previous study has evaluated whether there was a difference in EEG power spectrum ranges between propofol and sevoflurane, the two main anesthetic agents for maintenance of general anesthesia, in order to define a cut-off value for the prediction of a higher risk of postoperative delirium.

* Primary objective: comparison of EEG alpha power (dB) during maintenance of anesthesia with propofol and sevoflurane using data available in the NeuroSense® depth-of-anesthesia monitoring * Secondary objectives: comparison of other EEG frequency bands during maintenance of anesthesia with propofol and sevoflurane using data from the NeuroSense® depth-of-anesthesia monitoring

Eligibility criteria

Qualifiers

Capable to give informed consent

French-speaking patients

Disqualifiers

Need for a premedication with benzodiazepine before anesthesia

Reduced left ventricular ejection fraction (< 50%) or underlying cardiac pathology requiring a more balanced anesthesia (administration of benzodiazepine and/or ketamine during anesthesia)

Preoperative MoCA score < 26/30 (for patients > ou = 55 years old)

Patients treated with anti-epileptic drugs

Trial design

Treatments tested in this trial

  • Maintenance of general anesthesia by Propofol
  • Maintenance of general anesthesia by Sevoflurane

Treatment groups

280 Participants
are divided into 2 treatment groups